Miragen Therapeutics, Inc. Stock News

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 18) * ADC Therapeutics SA (NYSE: ADCT) * Adverum Biotech

BOULDER, Colo., June 18, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, to

Companies in the news are: WATT, ARMP, MGEN, CEMI

BOULDER, Colo., June 16, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, to

A new poll finds a large majority of Michigan voters are uncertain if Sen. Gary Peters should be reelected in November. | Politics

African explorer MRG Metals (ASX: MRQ) has confirmed “extensive high-grade” heavy mineral sand mineralisation at the Poiombo target within its Corridor South project in Mozambique.

Group representing 2 300 stores says its members do not qualify for SMME relief, but cannot pay full rentals when consumers aren’t spending.

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Ev

Which stocks are leading the pack out on Wall Street? Biotechs. Understandably, investors have taken a more cautious approach when navigating the confused

Which stocks are leading the pack out on Wall Street? Biotechs. Understandably, investors have taken a more cautious approach when navigating the confused financial environment, but focus is locking i

BOULDER, Colo., May 26, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, tod

Miragen Therapeutics (NASDAQ:MGEN) shareholders will doubtless be very grateful to see the share price up 43% in the...

Miragen Therapeutics, Inc. (NASDAQ:MGEN) Q1 2020 Earnings Conference Call May 7, 2020 16:30 ET Company Participants Dan Ferry - Managing Director of LifeSci Adv

BOULDER, Colo., May 07, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), today provided operational highlights and financial results for the first quarter ended March 31, 2020. Prior to

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 6.) Adverum Biotechnologies Inc...